Aurobindo Pharma on Thursday said the US health regulator has issued a Form 483 with five observations after inspecting Andhra Pradesh-based Unit-IV of its subsidiary APL Healthcare.
The US Food and Drug Administration (USFDA) inspected the unit …
The US Food and Drug Administration (USFDA) inspected the unit …





